Pfizer-BioNTech Current Affairs, GK & News

Sri Lanka seeks $100-mn IMF loan to procure Covid Vaccine

Sri Lanka is seeking for a $100 million loan from the International Monetary Fund (IMF) in order to procure 14 million doses of the Pfizer Covid-19 vaccine. Highlights With this loan, Sri Lanka would also finance other vaccination programme related costs. This proposal was put forward by the Minister of Health Keheliya Rambukwella. Sri Lanka ..

Month: 

Category: 

Topics: 

Can Antibodies post vaccine fight Delta variant?

According to a lab study conducted in US, Delta variant of the SARS-CoV-2 virus cannot evade antibodies generated by vaccination. Key Points Findings were published in journal ‘Immunity’. It helped in explaining why vaccinated people have escaped the worst of Delta variant surge. Researchers from Washington University School of Medicine, US analysed the panel of ..

Month: 

Category: 

Topics: 

Japan to help India build Vaccine Cold Chain Facilities

Japan is all set to provide India a $10 million assistance for building cold chain facilities to safely store covid-19 vaccines. Key Points Japan will provide this assistance to India to build cold chain equipment including medical equipment like cold-storage facilities. Cold storage facilities will be built as ‘Last One Mile Support’. These facilities will ..

Month: 

Category: 

Topics: 

Canada approves Mixing & Matching Covid-19 vaccine brands

Canada has recommended “mixing and matching” of AstraZeneca, Pfizer and Moderna Covid-19 vaccines. NACI Guidelines National Advisory Committee on Immunization (NACI) had issued guidelines for provinces and territories on mixing and matching second doses of Covid-19 vaccines. It has advised Canadians to combine either “AstraZeneca-Oxford, Pfizer-BioNTech or Moderna shots” interchangeably for specific situations. NACI recommended ..

Month: 

Category: 

Topics: 

WHO clears Chinese Vaccine Sinovac for global use

World Health Organisation (WHO) has given approval for global use of covid-19 Vaccine by Sinovac Biotech Ltd. Of China. Highlights WHO recommended its use for people above 18 years. Two-dose will be scheduled for it, with a gap of two to four weeks between shots. Sinopharm Group Co. had secured WHO’s approval for emergency use ..

Month: 

Category: 

Topics: